Home › NDC Lookup › RxCUI directory › RxCUI 1092360

Rufinamide 40 MG/ML Oral Suspension [Banzel] — RxCUI 1092360

Name: Rufinamide 40 MG/ML Oral Suspension [Banzel] (RxCUI 1092360)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 1092360 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1092360

Official nameRufinamide 40 MG/ML Oral Suspension [Banzel]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asBanzel 40 MG/ML Oral Suspension; BANZEL 40 MG in 1 mL Oral Suspension; Banzel 40 MG per 1 ML Oral Suspension

FDA products mapped3

Package NDCs mapped5

Reported Medicaid activity (SDUD)16,246 prescriptions · 36 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Rufinamide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Rufinamide — sold as Banzel — is used to help control seizures in people with Lennox-Gastaut Syndrome (LGS), a severe form of epilepsy that often starts in childhood. It's always u...
Yes — this one really matters. Food significantly increases how much rufinamide your body absorbs, so taking it on an empty stomach means you could be getting much less of the medi...
Do I really need to take it with food every time?
The most common ones are drowsiness, headache, dizziness, nausea or vomiting, and feeling tired — these are annoying but generally manageable. The ones that need a call to your doc...

📖 Read our full Rufinamide guide →

🕸️ Concept Web — How Rufinamide 40 MG/ML Oral Suspension [Banzel] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Rufinamide 40 MG/ML Oral Suspension [Banzel] RxCUI 1092360 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Rufinamide 69036 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Banzel 824296 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Rufinamide Oral Suspension 1092356 SCDF
- Rufinamide Oral Liquid Product 1157999 SCDG
- Rufinamide Oral Product 1158000 SCDG
- Rufinamide Oral Suspension [Banzel] 1092359 SBDF
- Banzel Oral Liquid Product 1168001 SBDG
- Banzel Oral Product 1168002 SBDG
- Oral Suspension 316969 DF
- Oral Liquid Product 1151137 DFG
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Rufinamide 40 MG/ML Oral Suspension 1092357 SCD
- Rufinamide 40 MG/ML 1092355 SCDC
- Rufinamide 40 MG/ML [Banzel] 1092358 SBDC

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Rufinamide 40 MG/ML Oral Suspension SCD · 1092357
Rufinamide 40 MG/ML SCDC · 1092355
Rufinamide Oral Suspension SCDF · 1092356
Rufinamide Oral Liquid Product SCDG · 1157999
Rufinamide Oral Product SCDG · 1158000

Brand-Name Concepts

Rufinamide 40 MG/ML [Banzel] SBDC · 1092358
Rufinamide Oral Suspension [Banzel] SBDF · 1092359
Banzel Oral Liquid Product SBDG · 1168001
Banzel Oral Product SBDG · 1168002
Banzel BN · 824296

📦 FDA Products & Package NDCs

3 products · 5 package NDCs

5 package NDCs map to RxCUI 1092360 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
62856-0582-04	4 TABLET, FILM COATED in 1 BOTTLE (62856-582-04)	Banzel	Eisai Inc.	2018-08-08
62856-0582-52	120 TABLET, FILM COATED in 1 BOTTLE (62856-582-52)	Banzel	Eisai Inc.	2008-11-14
62856-0583-14	14 TABLET, FILM COATED in 1 BOTTLE (62856-583-14)	Banzel	Eisai Inc.	2018-08-08
62856-0583-52	120 TABLET, FILM COATED in 1 BOTTLE (62856-583-52)	Banzel	Eisai Inc.	2008-11-14
62856-0584-46	1 BOTTLE in 1 CARTON (62856-584-46) / 460 mL in 1 BOTTLE	Banzel	Eisai Inc.	2011-03-03

Observed labelers: Eisai Inc. (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.